Prerecovery liver biopsy in the brain-dead donor: A case-control study of logistics, safety, precision, and utility

Liver Transplantation

Volumn 20, Issue 2, 2014, Pages 237-244

  Oliver, Joseph Benton ^a   Peters, Stephen ^a   Bongu, Advaith ^a   Beidas, Abdel Kareem ^a   Dikdan, George ^a   Brown, Lloyd ^a   Koneru, Baburao ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BIOPSY; BRAIN DEATH; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEW JERSEY; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; TISSUE AND ORGAN HARVESTING; TISSUE DONORS; YOUNG ADULT;

EID: 84895039617     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23786     Document Type: Article

References (27)

1. Orman ES, Barritt AS IV, Wheeler SB, Hayashi PH,. Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death. Liver Transpl 2013; 19: 59-68.
2. Ganz S, Abdullah K, Gedaly R, Henry S, Cravero L, Olson L, et al. Use of percutaneous liver biopsies in marginal liver donors. Transplant Proc 2001; 33: 1509-1511.
3. Busuttil RW, Tanaka K,. The utility of marginal donors in liver transplantation. Liver Transpl 2003; 9: 651-663.
4. Salizzoni M, Franchello A, Zamboni F, Ricchiuti A, Cocchis D, Fop F, et al. Marginal grafts: finding the correct treatment for fatty livers. Transpl Int 2003; 16: 486-493.
5. Frankel WL, Tranovich JG, Salter L, Bumgardner G, Baker P,. The optimal number of donor biopsy sites to evaluate liver histology for transplantation. Liver Transpl 2002; 8: 1044-1050.
6. Maharaj B, Bhoora IG,. Complications associated with percutaneous needle biopsy of the liver when one, two or three specimens are taken. Postgrad Med J 1992; 68: 964-967.
7. Myers RP, Fong A, Shaheen AA,. Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies. Liver Int 2008; 28: 705-712.
8. Perrault J, McGill DB, Ott BJ, Taylor WF,. Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology 1978; 74: 103-106.
9. Abdi W, Millan JC, Mezey E,. Sampling variability on percutaneous liver biopsy. Arch Intern Med 1979; 139: 667-669.
10. Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, Pudifin DJ,. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1: 523-525.
11. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-2618.
12. Winkfield B, Aubé C, Burtin P, Calès P,. Inter-observer and intra-observer variability in hepatology. Eur J Gastroenterol Hepatol 2003; 15: 959-966.
13. Merriman RB, Ferrell LD, Patti MG, Weston SR, Pabst MS, Aouizerat BE, Bass NM,. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 2006; 44: 874-880.
14. Heller B, Peters S,. Assessment of liver transplant donor biopsies for steatosis using frozen section: accuracy and possible impact on transplantation. J Clin Med Res 2011; 3: 191-194.
15. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al.; for STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 2007; 4: e297.
16. Batts KP, Ludwig J,. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995; 19: 1409-1417.
17. Sim J, Wright CC,. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther 2005; 85: 257-268.
18. Nadalin S, Malagõ M, Valentin-Gamazo C, Testa G, Baba HA, Liu C, et al. Preoperative donor liver biopsy for adult living donor liver transplantation: risks and benefits. Liver Transpl 2005; 11: 980-986.
19. Ryan CK, Johnson LA, Germin BI, Marcos A,. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl 2002; 8: 1114-1122.
20. Savas N, Coskun M, Bilezikci B, Uruc I, Karakayali H, Yilmaz U, Haberal M,. Value of an individual liver biopsy in the preoperative evaluation of apparently healthy potential liver donors. Liver Transpl 2008; 14: 541-546.
21. Simpson MA, Verbesey JE, Khettry U, Morin DS, Gordon FD, Burns DL, et al. Successful algorithm for selective liver biopsy in the right hepatic lobe live donor (RHLD). Am J Transplant 2008; 8: 832-838.
22. Valentín-Gamazo C, Malagõ M, Karliova M, Lutz JT, Frilling A, Nadalin S, et al. Experience after the evaluation of 700 potential donors for living donor liver transplantation in a single center. Liver Transpl 2004; 10: 1087-1096.
23. Iwasaki M, Takada Y, Hayashi M, Minamiguchi S, Haga H, Maetani Y, et al. Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation 2004; 78: 1501-1505.
24. Joy D, Thava VR, Scott BB,. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 2003; 15: 539-543.
25. Mazhar SM, Shiehmorteza M, Sirlin CB,. Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol 2009; 7: 135-140.
26. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-750.
27. Inaba K, Branco BC, Lam L, Salim A, Talving P, Plurad D, et al. Organ donation and time to procurement: late is not too late. J Trauma 2010; 68: 1362-1366.